ACM vs CNH

ACM's Piotroski F-Score of 5/9 indicates stable financial health, though the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to both the Graham Number ($44.91) and intrinsic value ($33.18), currently priced at $97.08, suggesting overvaluation. Despite solid ROE of 28.09% and a history of consistent earnings beats (22 of 25 quarters), recent YoY earnings decline (-29.10%) and insider selling raise concerns. Analysts maintain a 'buy' recommendation with a $130.33 target, implying 24% upside, but weak technical trend (0/100) and bearish insider activity temper near-term optimism.

CNH presents a conflicting profile: a strong Piotroski F-Score of 7/9 indicates solid operational health, yet the stock is plagued by a severe earnings collapse (-50.10% YoY) and a completely bearish technical trend (0/100). While the PEG ratio of 0.60 suggests significant undervaluation relative to growth potential, the current price of $10.25 trades at a premium to the Graham Number ($7.58) and the growth-based intrinsic value ($2.87). The disconnect between bullish analyst targets ($13.88) and the consistent multi-year price decline suggests a value trap risk despite strong short-term liquidity.